PMC:7402624 / 21674-21895
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T162","span":{"begin":73,"end":77},"obj":"Body_part"},{"id":"T163","span":{"begin":112,"end":116},"obj":"Body_part"},{"id":"T164","span":{"begin":164,"end":169},"obj":"Body_part"}],"attributes":[{"id":"A162","pred":"fma_id","subj":"T162","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A163","pred":"fma_id","subj":"T163","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A164","pred":"fma_id","subj":"T164","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"(A) Representative flow cytometry plots of the gating strategy for CD4 T cell subsets. (B) Frequencies of CD4 T cell subsets as indicated. (C) Frequencies of KI67+ cells; green line at upper decile of healthy donors (HD)."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"773","span":{"begin":67,"end":70},"obj":"Gene"},{"id":"774","span":{"begin":106,"end":109},"obj":"Gene"},{"id":"790","span":{"begin":217,"end":219},"obj":"Disease"}],"attributes":[{"id":"A773","pred":"tao:has_database_id","subj":"773","obj":"Gene:920"},{"id":"A774","pred":"tao:has_database_id","subj":"774","obj":"Gene:920"},{"id":"A790","pred":"tao:has_database_id","subj":"790","obj":"MESH:D006816"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"(A) Representative flow cytometry plots of the gating strategy for CD4 T cell subsets. (B) Frequencies of CD4 T cell subsets as indicated. (C) Frequencies of KI67+ cells; green line at upper decile of healthy donors (HD)."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T155","span":{"begin":217,"end":219},"obj":"Disease"}],"attributes":[{"id":"A155","pred":"mondo_id","subj":"T155","obj":"http://purl.obolibrary.org/obo/MONDO_0007739"}],"text":"(A) Representative flow cytometry plots of the gating strategy for CD4 T cell subsets. (B) Frequencies of CD4 T cell subsets as indicated. (C) Frequencies of KI67+ cells; green line at upper decile of healthy donors (HD)."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T391","span":{"begin":1,"end":2},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T392","span":{"begin":67,"end":70},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T393","span":{"begin":71,"end":77},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T394","span":{"begin":88,"end":89},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T395","span":{"begin":106,"end":109},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T396","span":{"begin":110,"end":116},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T397","span":{"begin":164,"end":169},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"(A) Representative flow cytometry plots of the gating strategy for CD4 T cell subsets. (B) Frequencies of CD4 T cell subsets as indicated. (C) Frequencies of KI67+ cells; green line at upper decile of healthy donors (HD)."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T116","span":{"begin":217,"end":219},"obj":"Chemical"}],"attributes":[{"id":"A116","pred":"chebi_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/CHEBI_73925"}],"text":"(A) Representative flow cytometry plots of the gating strategy for CD4 T cell subsets. (B) Frequencies of CD4 T cell subsets as indicated. (C) Frequencies of KI67+ cells; green line at upper decile of healthy donors (HD)."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T135","span":{"begin":0,"end":221},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"(A) Representative flow cytometry plots of the gating strategy for CD4 T cell subsets. (B) Frequencies of CD4 T cell subsets as indicated. (C) Frequencies of KI67+ cells; green line at upper decile of healthy donors (HD)."}